Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
D000328:Adult; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008266:Macula Lutea / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016684:Prone Position; D011994:Recombinant Proteins; D012166:Retinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D012591:Scleral Buckling / Q000009:adverse effects*; D013459:Sulfur Hexafluoride / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome; D014792:Visual Acuity; D014822:Vitreous Body; D014823:Vitreous Hemorrhage / Q000175:diagnosis